NAD refers skin care claims to FDA
This article was originally published in The Tan Sheet
Executive Summary
National Advertising Division finds Pinnacle Marketing has "failed to provide any substantiating information" for its Acadia Skin Care product and has thus referred the case to FDA. In an upcoming NAD Case Report, Council of Better Business Bureaus division challenges print ads claiming Acadia "will help relieve the irritation and embarrassment of psoriasis, eczema, seborrheic dermatitis, rough, dry skin and dandruff," and that product's "active ingredients are FDA approved." In response, Pinnacle maintained claims at issue could be substantiated but said it would not do so "for economic reasons"...